Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2011/0301133 COMPOSITIONS OF PROTEIN RECEPTOR TYROSINE KINASE INHIBITORS
The present invention relates to novel synthetic substituted heterocyclic compounds and pharmaceutical compositions containing the same that are capable of...
2011/0301132 METHODS OF TREATING URETHRITIS AND RELATED INFECTIONS USING FUSIDIC ACID
Methods for the treatment and prevention of a bacterial infection caused by Neisseria gonorrhoeae, or Chlamydia trachomatis, or both Neisseria gonorrhoeae and...
2011/0301131 Drug Delivery Implants and Processes for Their Preparation
The invention discloses an implant suitable for delivery of at least one drug, the implant comprising a fibrillar collagen matrix having, as measured in Example...
2011/0301130 TOPICAL COMPOSITION FOR THE TREATMENT OF ACTINIC KERATOSIS
The invention relates to a topical gel composition for use in the treatment of actinic keratosis comprising (a) an active agent for treatment of actinic...
2011/0301129 GASTRIC RETENTIVE ORAL DOSAGE FORM WITH RESTRICTED DRUG RELEASE IN THE LOWER GASTROINTESTINAL TRACT
Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal...
2011/0301128 Pyrrole Derivatives As Pharmaceutical Agents
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating...
2011/0301127 METHODS OF REDUCING MICROBIAL RESISTANCE TO DRUGS
The instant methods and compositions represent an advance in controlling drug resistance in microbes. AcrAB-like efflux pumps have been found to control...
2011/0301126 PESTICIDAL CONTROL DEVICE WITH HIGH LOAD OF ACTIVE INGREDIENT
The present invention relates to a pesticidal control device that includes at least one pesticidal active ingredient, cellulose fibers, and a polymer or polymer...
2011/0301125 Method for Treating Macular Degeneration
Provided herein are novel and useful methods for preventing, treating, or ameliorating a macular degeneration such as dry macular degeneration, wet macular...
2011/0301124 PROTEASOME INHIBITORS
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds...
2011/0301123 Fungicidal Heterocyclic Amines
Disclosed are compounds of Formula 1, N-oxides, and salts thereof, ##STR00001## wherein R.sup.1, R.sup.2, R.sup.9a, R.sup.9b, G, W, X, Y, and Z are as defined...
2011/0301122 HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS
The present application relates to novel substituted aryl compounds, processes for their preparation, their use for treatment and/or prevention of diseases and...
2011/0301121 HYDROGEL OF POLYSACCHARIDE DERIVATIVE
A nerve dysfunction repairing material including a hydrogel of a polysaccharide derivative that has, in a 0.5 wt % aqueous solution, a complex modulus of 1 to...
2011/0301120 USE OF A CHITOSAN POLYMER FOR HEPARIN NEUTRALIZATION
Use of a chitosan polymer for direct neutralization of heparin in blood and physiological fluids of mammals. The chitosan polymer may be applied as an...
2011/0301119 PHARMACEUTICAL COMPOSITIONS CONTAINING FUCOIDAN FOR STIMULATING AND ACTIVATING OSTEOGENESIS
The present invention relates to pharmaceutical compositions containing fucoidan for stimulating and activating osteogenesis. The compositions according to the...
2011/0301118 Methods of treatment utilising glucan formulations
The present invention relates to methods for the treatment of skin wounds or lesions, and connective tissue damage or injury, comprising administering to a...
2011/0301117 CRYOGENIC SKIN CREAM AND METHOD
A skin cream and skin cream packaging arrangement is disclosed. The arrangement includes, in combination: a skin cream intended to be applied on human skin and...
2011/0301116 NSAIDS-INDUCED GASTROINTESTINAL MUCOSAL DISORDER ALLEVIATOR AND MANUFACTURING METHOD THEREOF
[Problems] The object of the present invention is to provide a Medical Drugs which reduce damage of gastrointestinal mucosal induced by NSAIDs. [Means for Solving...
2011/0301115 Methods of Treating Subclinical Sun Damage
Provided are methods of treating subclinical sun damage and of inducing a chemocytotoxic response in skin. Methods of treating subclinical sun damage include...
2011/0301114 AMPHIPHILE PRODRUGS
Amphiphilic prodrugs of general formula A-X are disclosed, wherein A is a biologically active agent or may be metabolised to a biologically active agent; and X...
2011/0301113 PYRIDINEAMINE DERIVATIVES
This invention relates to novel compounds that are pyrimidineamine derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention...
2011/0301112 FUSED RING THROMBIN RECEPTOR ANTAGONISTS
Fused-ring, heterocyclic-substituted tricyclics of the formula ##STR00001## or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic...
2011/0301111 CYCLIC ADENOSINE MONOPHOSPHATES FOR REDUCING THE FORMATION OF ADHESIONS
Provided herein are methods of reducing adhesion formation in a subject, for example, post-surgical abdominal and pelvic adhesions. The methods comprise...
2011/0301110 TRIM33 (TIF1gamma) AS A NEW DIAGNOSTIC MARKER OF CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
A method for diagnosing a chronic myelomonocytic leukemia (CMML) in a subject includes the steps of (i) determining the level of expression of the Trim33...
2011/0301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof
The present invention relates to a class of phenylpyrimidone compounds, the pharmaceutical composition, the preparation method and the use thereof. More...
2011/0301108 MATERIALS AND METHODS FOR SENSITIZING MULTIDRUG RESISTANT CELLS
Disclosed herein are materials and methods for sensitizing multidrug resistant cancer cells that express ABCG2 and related proteins members of a family of...
2011/0301107 DERIVATIVES OF MORPHINE-6-GLUCURONIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS
The disclosure relates to derivatives of morphine-6-glucuronide of formula (I) ##STR00001## wherein R1 is as defined in the disclosure, or an acid addition salt ...
2011/0301106 Use of Icariside II in Manufacture of Products for Preventing or Treating Male or Female Sexual Dysfunction
The present invention provides the use of icariside II or extract comprising thereof in manufacture of products for preventing or treating male or female sexual...
2011/0301105 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS
We have discovered that p63 inhibition results in increased cellular proliferation. We have also performed a screen for agents capable of increasing cellular...
2011/0301104 Transition state structure of orotate phosphoribosyl transferases and uses thereof
Methods are provided for designing a transition state inhibitor of orotate phosphoribosyltransferase (OPRT) and for inhibiting OPRT.
2011/0301103 Methods of Treatment
The present disclosure provides a biochemical basis of nephrotic syndrome and provides and explanation for the observed proteinuria and other effects. As a...
2011/0301102 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME
This invention relates to specific treatment regimens for treating myelodysplastic syndrome.
2011/0301101 T cell immune balance peptides
This invention is related to a peptides mixture. Without the need to consider the patients' genetic background, it can interfere with MHC-pathogenic peptide-TCR...
2011/0301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a ...
2011/0301099 Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small...
A method and composition that allows for the penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with...
2011/0301098 TREATMENT FOR INTIMAL HYPERPLASIA AND RELATED CONDITIONS
The present invention provides a method of prevention or treatment of intimal hyperplasia in blood vessel walls, the method comprising the step of administering...
2011/0301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
The present invention is directed toward a composition for widespread distribution, systemic expression and sustained delivery of a therapeutic agent and to a...
2011/0301096 PRODRUG OF AN ICE INHIBITOR
This invention describes an ICE inhibitor prodrug (I) having good bioavailability. ##STR00001## Compound I is useful for treating IL-1 mediated diseases such as ...
2011/0301095 METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASIS
Disclosed are methods, compounds, and compositions for detection, diagnosis, prognosis, monitoring, treatment, monitoring treatment, and selecting treatment of...
2011/0301094 NEW TUMOR SUPPRESSOR GENE, P28ING5
This disclosure provides a novel tumor suppressor, referred to as p28ING5, nucleic acid molecules encoding this protein, and methods of making and using these...
2011/0301093 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these...
2011/0301092 THE USE OF A NON-GLYCANATED POLYPEPTIDE FOR TREATING A CANCER
The use of a non-glycanated form of a polypeptide including an amino acid sequence having at least 90% amino acid identity with an amino acid sequence selected...
2011/0301091 COMPOSITIONS AND METHODS FOR REDUCING THE SIGNS OF AGING OF THE SKIN
Compositions and methods used to reduce the visible signs of aging of the skin by recalibrating the expression of genes, genetic networks, and cellular pathways...
2011/0301090 SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF
A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A...
2011/0301089 ADIPONECTIN RECEPTOR FRAGMENTS AND METHODS OF USE
Methods are disclosed of treating diabetes, abnormal adipocyte activity, and insulin resistance using C-terminal fragments of adiponectin receptor R1. Methods...
2011/0301088 CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE
Crystalline ezatiostat hydrochloride ansolvate form D is more stable and/or more soluble that various solvated crystalline polymorphic forms of ezatiostat...
2011/0301087 CRF1 RECEPTOR COMPOUNDS
The invention relates generally to compounds which are allosteric modulators (e.g., negative and positive allosteric modulators, allosteric agonists, and...
2011/0301086 Complex polymere amphiphile-PDGF
Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic...
2011/0301085 PROTEIN HYDROLYSATE AND PLANT STEROL CONTAINING COMPOSITION FOR IMPROVING SERUM LIPID PROFILE AND PREVENTING...
The invention relates to a terapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the...
2011/0301084 Protracted Exendin-4 Compounds
Novel protracted exendin-4 compounds and therapeutic uses thereof.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.